 metabol consider choic therapi patient hypertens object patient hypertens blood pressur associ morbid mortal recent assess clinic trial risk stroke antihypertens therapi degre success coronari arteri diseas cad mani explan cad possibl therapi clinic trial diuret beta-adrenoreceptor blocker patient risk coronari atherosclerosi lethal arrhythmia class antihypertens agent initi therapi diuret beta-adrenoreceptor blocker angiotensin-convert enzym ace inhibitor calcium entri blocker metabol effect thiazid diuret electrolyt disturb hypokalemia hypomagnesemia hyponatremia dyslipidemia increas triglycerid abnorm glucos metabol hyperglycemia hyperinsulinemia peripher insulin resist hyperuricemia beta-adrenoreceptor blocker mani metabol advers reaction beta-adrenoreceptor blocker intrins sympathomimet activ isa dyslipidemia high-dens lipoprotein cholesterol triglycerid abnorm glucos metabol hyperglycemia hyperinsulinemia peripher insulin resist beta-adrenoreceptor blocker isa third-gener beta-block select partial agonist activ celiprolol dilevalol dyslipidemia date abnorm glucos metabol ace inhibitor triglycerid high-dens lipoprotein cholesterol captopril insulin sensit calcium entri blocker neutral